Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.77162 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.72511 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.72691 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.63163 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.70611 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.97024 | 39 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.76443 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.70325 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.69849 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.71638 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.71169 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.68158 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.72135 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.71953 | 32 |